Now I have enough data to calibrate. Let me finalize my assessment.

**Initial bracket: 5.5–7.0**

Key calibration comparisons:
- **Protein-ligand binding representation learning** (score 5.67, accepted): Topically very similar but less rigorous than ProteinVista (missing interaction analysis, label leakage concerns). ProteinVista is clearly stronger.
- **MAPE-PPI** (score 5.67, accepted): Similar strengths/weaknesses profile but ProteinVista has better experimental rigor (identical pipelines, statistical tests).
- **AtomSurf** (score 6.75, accepted): Most comparable paper. Fair benchmarks, SOTA on Atom3D. ProteinVista has comparable rigor but AtomSurf's methodological contribution (surface+graph integration) is more novel.
- **Equivariant Scalar Fields** (score 6.33, accepted): Solid contribution with novel method. ProteinVista has similar quality.
- **ProteiNexus** (score 3.67, rejected): Similar topic but much weaker - unclear data splits, possible leakage, poor ablation. ProteinVista is clearly much better.
- **bio2token** (score 5.0, rejected): Atom-level tokenization - reasonable paper but different contribution type. Not a strong comparator.

ProteinVista sits between MAPE-PPI (5.67) and AtomSurf (6.75). Its experimental rigor (identical pipelines, statistical tests, comprehensive ablation and stratified analysis) is better than most anchors in the 5-6 range. The missing graph baseline and overclaimed scope are significant but not fatal - they weaken the headline claims without invalidating the empirical results. I'll settle on **6.0**.

## Summary
ProteinVista is a 123M-parameter 3D CNN that voxelizes full-atom protein structures into 5-channel density grids (C, N, O, S, P at 1.0 Å resolution) and is pre-trained on ~500K AlphaFold-2 structures via contrastive alignment to ESM-2 embeddings. It outperforms ESM-2 on protein-ligand binding tasks (transporter-substrate classification, enzyme-substrate classification, IC₅₀ regression) and honestly reports underperformance on GO annotation, demonstrating complementarity between structure and sequence encoders.

## Strengths
- **Rigorous controlled comparison with statistical validation**: All models receive identical prediction heads, identical MolFormer small-molecule embeddings, identical hyperparameter searches, and identical evaluation protocols (Tables 1–2, Section 3.1–3.2). McNemar's test (p < 10⁻¹³, p < 10⁻¹⁷) and Wilcoxon signed-rank test (p < 10⁻³⁰⁴) provide appropriate statistical significance testing. This isolates the protein encoder as the sole variable.
- **Dramatic compute efficiency with convincing evidence**: ProteinVista achieves comparable or superior performance with 123M parameters vs 650M for ESM-2_650M, using ~1% of pre-training GPU-hours (48 hours on 4 A100s vs 7 days on 128 H100s) and ~500K structures vs ~250M sequences (Section 4.3, Figure 3).
- **Insightful stratified analysis**: Partitioning by sequence identity, TM-score, and pLDDT (Section 4.1, Figure 2a–c) reveals precisely when ProteinVista excels (high-confidence structures, close training homologs) and when the ensemble helps most (low similarity), providing actionable guidance for practitioners.
- **Honest treatment of limitations**: The GO annotation experiment (Section 3.4) demonstrates ProteinVista underperforms ESM-2 on homology-reliant tasks (Fmax 0.57 vs 0.62). The paper also honestly quantifies storage costs (75 GB vs 3 MB) and acknowledges the ESM-2 dependency in pre-training.

## Weaknesses

### Fatal
None

### Major
- **Missing comparison with graph-based structure-aware baselines undermines the central thesis**: The introduction (paragraphs 3–5) argues that residue-level graph methods (GearNet, ESM-GearNet, DeepFRI) are insufficient because they "ignore the precise arrangement of atoms." This is the paper's core motivation for full-atom voxelization. However, the experimental evaluation never compares ProteinVista against any graph-based structure method on the same benchmarks. The only controlled comparison is against sequence-only ESM-2. The SOTA baselines in Table 1 (SPOT, ProSmith-ESP, Fusion_ESP) are not described in terms of architecture or whether they use structural information. Without a graph-structure baseline, it is impossible to determine whether ProteinVista's gains come from atom-level resolution specifically or merely from using any structural information at all. A single comparison with ESM-GearNet on the same benchmarks would directly test the paper's central claim.

- **Headline claim overstates the evidence**: The abstract concludes that "full-atom 3D CNNs are both tractable and superior than protein transformers for structure-dependent tasks." The evidence supports superiority on three protein-ligand binding benchmarks only. The GO annotation experiment (Section 3.4) shows ESM-2 outperforms ProteinVista on a different structure-dependent task. Protein function prediction, protein-protein interaction, enzyme commission number prediction, and mutation effect prediction are all "structure-dependent tasks" that are not evaluated. The claim should be scoped to "protein-ligand binding and affinity prediction."

### Minor
- **Inference cost understated in runtime comparison**: Section 4.3 reports ProteinVista processes 1K proteins in 20 seconds vs 426 seconds for ESM-2_650M. However, the ablation (Section 4.2, Figure 2e) shows that reducing from 5 inference views to 1 causes a 5.5–6.4% R² drop, meaning production inference requires 5 augmented forward passes. The effective time is ~100 seconds, not 20 seconds — still faster, but the reported 20× speedup overstates the practical advantage.

- **Numerical discrepancies between text and ablation table**: Section 4.2 states that disabling training augmentation had "virtually no impact (−0.1%)" but Figure 2e's table shows ~0.4%; text states 10 vs 5 predictions yields "0.9% gain" while the table shows ~1.8%; text states 1 vs 5 predictions drops R² by "6.4%" while the table shows ~5.5%. These inconsistencies undermine confidence in the reported magnitudes.

- **No variance estimates reported**: All metrics are single-point estimates. Given stochasticity from random initialization and augmentation, the binary classification gaps (1–2% accuracy) could shift with different seeds. At least 3–5 runs with standard deviations should be reported.

### Trivial
- The abstract's claim about "more than two orders of magnitude less data" compares protein count (500K vs 250M sequences), not data volume — each 3D structure is a dense representation with far more information per entry than a linear sequence.

## Nice-to-Haves
- Stratify performance by protein size to assess bias from the 160³ Å³ cropping of large proteins, and report how many test proteins are affected.
- Discuss the Rosetta pre-training alternative as a path to a fully PLM-independent model, especially since the ablation shows it yields only ~1% worse R².
- Provide Grad-CAM or similar visualization to illuminate which voxels drive predictions — the paper mentions this as future work but it would significantly strengthen the contribution.

## Removed Points
These points are flagged to be removed, treat them with caution:
- **Parser artifact about density formula** (line 57): The formula "$\vec{v} = \exp(-\|\vec{v} - \vec{r}\|/\sigma^2)$" appears to be a PDF parsing error for a Gaussian kernel. This is not a paper flaw.
- **Missing related works**: Cannot verify existence of external references not cited in the paper.
- **Storage overhead criticism**: The paper explicitly and honestly quantifies this trade-off in Section 4.3 and Figure 3d.
- **Formatting/style nitpicks**: All parser artifacts, not author errors.

## Novel Insights
The stratified analysis in Section 4.1 provides genuinely useful insight: ProteinVista's advantage is concentrated in high-confidence structures with close training homologs, while the ensemble with ESM-2 helps most at low similarity — a practical finding for practitioners deciding when to use structure-based models. The ablation finding that training-time augmentation has negligible impact after pre-training but inference-time multi-view averaging is critical reveals that contrastive pre-training instills partial rotation robustness. This is practically useful for deploying 3D CNNs on proteins and suggests that pre-training objectives can substitute for explicit equivariance.

## Suggestions
- Add at least one graph-based structure method (e.g., ESM-GearNet) as a baseline to directly test whether atom-level detail matters more than residue-level connectivity.
- Scope the conclusion to binding/affinity tasks rather than all "structure-dependent tasks."
- Report inference runtime with 5-view augmentation factored in for honest comparison.
- Report mean ± std across multiple training runs for all main results.

## Calibration Anchors

| Round | Anchor | Avg Score | Comparison |
|-------|--------|-----------|------------|
| 1 | 3D Molecular Pretraining (LEGO) | 3.0 | Much weaker methodology and evaluation; ProteinVista clearly stronger |
| 1 | ProteinAdapter | 3.4 | Similar topic but much weaker; data splits unclear, poor ablation |
| 1 | ProteiNexus | 3.67 | Structural pre-training but serious data leakage and evaluation concerns |
| 1 | RapidDock | 4.25 | Docking paper with limited evaluation; ProteinVista more rigorous |
| 1 | bio2token | 5.0 | Atom-level tokenization; different contribution type, reasonable quality |
| 1 | Protein-ligand binding repr. learning | 5.67 | Topically very similar, accepted; ProteinVista has better experimental rigor |
| 1 | MAPE-PPI | 5.67 | Similar strengths/weaknesses; ProteinVista has better controlled comparison |
| 1 | Equivariant Scalar Fields | 6.33 | Accepted docking paper; comparable quality, more novel method |
| 1 | AtomSurf | 6.75 | Most comparable anchor; similar rigor but more novel method contribution |
| 1 | ProtComposer | 8.0 | Much stronger contribution; protein generation with novel conditioning |

**Bracket: 5.5–7.0.** ProteinVista's experimental rigor (identical pipelines, statistical tests, comprehensive analysis) places it above the 5.67 anchors (MAPE-PPI, binding repr. learning), but the missing graph baseline and overclaimed scope prevent it from reaching AtomSurf's 6.75. Final score: **6.0**.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>